American Association for Cancer Research (AACR) Annual Meeting 2014

by EpicentRx | Apr 18, 2014 | Conferences

Apr 2014, San Diego, California Abstract: Molecular imaging of RRx-001-induced oxidative stress in Nrf2-luciferase expressing SCC VII tumors in mice Abstract: RRx-001 inhibits glucose erythrocyte and tumor glucose 6-phosphate dehydrogenase Abstract: RRx-001 oxidation...

16th International Symposium on Anti-Angiogenic Therapy 2014

by EpicentRx | Feb 18, 2014 | Conferences

February 2014, La Jolla, California Abstract: Resensitization to previous chemotherapy with the novel hypomethylating anticancer agent RRx-001

American Chemical Society, Western Regional Meeting 2013

by EpicentRx | Oct 18, 2013 | Conferences

October 2013, Santa Clara, California Oral Presentation: High resolution MS proves that the developmental cancer drug, RRx-001, alkylates the hemoglobin beta chain

3rd International Workshop on Nitric Oxide in Cancer Therapy 2013

by EpicentRx | May 18, 2013 | Conferences

May 2013, Kingston, Ontario Abstract: RRx-001, a hypoxia activated, nitric oxide generating cytotoxic agent: Phase 1 study results

American Association for Cancer Research (AACR) Annual Meeting 2013

by EpicentRx | Apr 18, 2013 | Conferences

April 2013, Washington, D.C. Abstract: Preliminary results from an ongoing phase I trial of RRx-001, a tumor selective cytotoxic agent